The Small Business Innovation Research Program (SBIR) was established in 1983 to encourage and support continued scientific innovation in America, by helping to fund innovative research that has a focus toward commercialization of a product or service.

SBIR Backgrounder: Strengthen the SBIR Program
This backgrounder emphasizes the importance of strengthening the SBIR program to support bringing scientific innovation to the public.
Read the backgrounder

SBIR Testimony: James C. Greenwood, President and Chief Executive Officer, Biotechnology Industry Organization testifies before the House Committee on Science and Technology, Subcommittee on Technology and Innovation
The testimony highlights the role of the SBIR and the STTR programs in stimulating innovation at small high-tech businesses.
Read the statement.

SBIR Testimony: Rachel K. King, Chief Executive Officer, Glycomimetics, Inc. testifies before the House of Representatives Committee on Small Business
The testimony highlights the importance of technology in an economic recovery.
Read the statement

SBIR: Letter from Patient Groups
The letter, signed by approximately 60 patient groups, emphasizes support for restoring eligibility in the SBIR program to venture-backed bioscience companies.
Read the letter

SBIR: Letter from Biotech CEOs
The letter, signed by over 280 biotech executives, emphasizes support for restoring eligibility in the SBIR program to venture-backed bioscience companies.
Read the letter